MAPT and early-onset autosomal dominant Alzheimer disease: Tau’s clinical significance has been shown in a variety of neurodegenerative diseases (tauopathies) including Alzheimer’s disease, Pick’s disease, frontotemporal dementia, cortico-basal degeneration, and progressive supranuclear palsy (Chang et al., 2021; Song et al., 2021).